- Jul 26/24
A newly identified immune checkpoint protein may lead to future cancer therapies - Jul 26/24
New agreement to progress cardiovascular disease research - Jul 25/24
The route to enhanced gene therapies - Jul 24/24
How CSL Behring worked with EMA/FDA to develop Hemgenix potency assays - Jul 24/24
A foamy way to improve cost, efficiency and safety of gene therapy - Jul 24/24
Breakthrough gene therapy restores dystrophin protein in Duchenne muscular dystrophy - Jul 24/24
Cord blood banking: Experts raise concern over claims made for stem cell applications - Jul 24/24
Pfizer’s gene therapy for rare genetic bleeding disorder succeeds in late-stage trial - Jul 24/24
‘Encouraging’ results for potential disease-modifying ALS drug - Jul 23/24
Gene therapy discovery triggers hope for glaucoma patients - Jul 23/24
Restoring colour vision with gene therapy - Jul 22/24
CAR T-cell therapy may be a ‘miracle’ [for lupus], but it is too soon to say ‘cure’ - Jul 22/24
BlueRock Therapeutics assessing the potential of cell therapy for Parkinson’s disease with Phase 1 trial for bemdaneprocel - Jul 22/24
Opinion: This gene therapy may not work. So why did the FDA fully approve it? - Jul 22/24
Japanese scientists see stem cell potential for spinal degeneration - Jul 22/24
Nanoparticles deliver gene therapy directly to bone marrow - Jul 22/24
Molly Shoichet named inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine - Jul 20/24
An HIV patient is in remission after a unique stem cell transplant. Why it could be a path to a cure - Jul 19/24
New tech addresses manufacturing bottlenecks for a lifesaving blood cancer treatment - Jul 18/24
Stem cell therapy leads to short-term disability reduction in MS - Jul 17/24
In a first, patients with autoimmune diseases respond to allogeneic CAR-T treatment - Jul 17/24
New gene therapy for muscular dystrophy offers hope - Jul 17/24
Paving the way for future larynx transplants through regenerative science - Jul 17/24
Make gene therapies more available by manufacturing them in lower-income nations - Jul 17/24
The elite athlete concept for cell therapy - Jul 17/24
CAR T cells in a SNAP - Jul 16/24
Mini-retinas model human disease in a dish - Jul 15/24
FDA proposes cell and gene therapy site tours to help regulators learn from industry - Jul 15/24
Study identifies epigenetic ‘switches’ that regulate the developmental trajectories of single cells - Jul 15/24
Another state challenges FDA on biologics as Nevada OKs risky, unproven oligo, gene, and other therapies - Jul 14/24
Cell therapy offers ‘single shot’ hope to autoimmune disease patients - Jul 12/24
CAR-T cell therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies - Jul 12/24
This kids’ brain cancer is incurable – but immune therapy holds promise - Jul 12/24
All stem cell therapies are not created equally: Some don’t have many stem cells at all, researchers find - Jul 12/24
“Personalized” immunotherapy appears effective in small study of patients with metastatic solid tumours - Jul 11/24
New immune cell therapy benefits lab models of ALS and shows positive results in an individual with the disease - Jul 11/24
New technology could open up gene therapies to more patients at less cost - Jul 11/24
U.K. moves toward outcome-based payment model for first – and very expensive – gene therapy for hemophilia B - Jul 11/24
CRISPR gene therapy for progressive deafness preserves hearing in young adult mice - Jul 11/24
New gene editing technique offers hope for millions - Jul 11/24
A light-touch approach to intracellular delivery - Jul 10/24
Aspect Biosystems plans $200 million expansion - Jul 10/24
Allogeneic disc progenitor cells may improve outcomes for patients with disc degeneration - Jul 10/24
CAR T-cell therapy remains underutilized, despite improvements in access - Jul 9/24
Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation - Jul 9/24
Stem cell-derived therapy shows promise against treatment-resistant liver cancer - Jul 9/24
New one-step method to make multiple edits to a cell’s genome - Jul 9/24
World-first CAR T-cell therapy for child with lupus - Jul 9/24
Q&A: New strategy can improve cell therapy against cancer - Jul 9/24
A faster, simpler, cheaper cancer cell therapy is about to be tested in humans - Jul 8/24
Study highlights the importance of infection prevention after CAR-T cell therapy - Jul 8/24
SMART researchers pioneer production of CAR T-cells using high-density microfluidic bioreactor - Jul 8/24
Applying the art of origami to advance 3D bioprinting - Jul 8/24
AI-designed proteins work in stem cell study - Jul 8/24
Review paper unveils the potential of suppressor tRNA in gene therapy - Jul 8/24
Who will pay for gene therapy – and how? - Jul 6/24
FDA activity recap: June 2024 features expanded indication approval, a CRL, RMAT designations, and more